• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国退伍军人人群中质子泵抑制剂过度使用情况综述

Review of Proton Pump Inhibitor Overuse in the US Veteran Population.

作者信息

Metaxas Evdokia S, Bain Kevin T

机构信息

Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA.

Children's Hospital of Philadelphia, Philadelphia, PA, USA.

出版信息

J Pharm Technol. 2015 Aug;31(4):167-176. doi: 10.1177/8755122515575177. Epub 2015 Mar 9.

DOI:10.1177/8755122515575177
PMID:34860933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5990187/
Abstract

A growing body of evidence provides proof that proton pump inhibitors (PPIs) are overused in the general population and that such use is associated with adverse risks and unnecessary costs. Our objective was to systematically evaluate PPI overuse in the veteran population. A literature search using MEDLINE and CINHAL databases (1946-December 2014) was performed using the search term coupled with each of the following key words: , and . Searches were limited to studies and reviews in English language and human subjects. Additional references were identified from a review of literature citations. All articles that centrally addressed the issue of PPI overuse were evaluated, following the PRISMA guidelines for systematic reviews. Data were extracted into Microsoft Excel 2013. Articles that focused on the pediatric or non-US veteran populations were excluded. Among 30 articles included, 5 evaluated PPI overuse in veterans. The reported prevalence rate of PPI overuse in veterans ranged from 33% to 67%. Several cases reported PPI-associated -associated diarrhea and pneumonia. One Veterans Affairs center reported the total cost of PPI overuse to be more than $200 000 based on over-the-counter costs and more than $1.5 million based on average wholesale price cost. PPI overuse is common among veterans and exposes them to adverse risks and costs the system enormous dollars. Based on the findings of this review, we provide recommendations to curb PPI overuse among veterans and in the Veterans Affairs system.

摘要

越来越多的证据证明,质子泵抑制剂(PPI)在普通人群中存在过度使用的情况,而且这种使用与不良风险和不必要的成本相关。我们的目标是系统评估退伍军人中PPI的过度使用情况。使用MEDLINE和CINHAL数据库(1946年至2014年12月)进行文献检索,检索词与以下每个关键词组合使用: ,以及 。检索限于英文研究和综述以及人类受试者。通过对文献引用的回顾确定了其他参考文献。按照系统评价的PRISMA指南,对所有集中讨论PPI过度使用问题的文章进行了评估。数据被提取到Microsoft Excel 2013中。排除了关注儿科或非美国退伍军人人群的文章。在纳入的30篇文章中,有5篇评估了退伍军人中PPI的过度使用情况。报告的退伍军人中PPI过度使用的患病率在33%至67%之间。几例报告了与PPI相关的腹泻和肺炎。一个退伍军人事务中心报告,基于非处方成本,PPI过度使用的总成本超过20万美元,基于平均批发价格成本则超过150万美元。PPI的过度使用在退伍军人中很常见,使他们面临不良风险,并给系统带来巨大成本。基于本综述的结果,我们提出了遏制退伍军人及退伍军人事务系统中PPI过度使用的建议。

相似文献

1
Review of Proton Pump Inhibitor Overuse in the US Veteran Population.美国退伍军人人群中质子泵抑制剂过度使用情况综述
J Pharm Technol. 2015 Aug;31(4):167-176. doi: 10.1177/8755122515575177. Epub 2015 Mar 9.
2
Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.门诊环境中抗分泌治疗过度使用的程度和经济影响。
Am J Manag Care. 2010 Sep;16(9):e228-34.
3
Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population.退伍军人事务部人群中质子泵抑制剂非处方使用及药物成本过高的分析。
J Manag Care Pharm. 2012 Jan-Feb;18(1):63-7. doi: 10.18553/jmcp.2012.18.1.63.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Epidemiological Study Assessing the Overuse of Proton Pump Inhibitors in Lebanese Population.评估黎巴嫩人群中质子泵抑制剂过度使用情况的流行病学研究。
Middle East J Dig Dis. 2020 Oct;12(4):265-270. doi: 10.34172/mejdd.2020.192.
6
Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.对一项州雇员健康计划中与福利设计变更(包括质子泵抑制剂参考定价)相关的使用情况和药品成本结果进行的五年审查。
J Manag Care Pharm. 2011 Apr;17(3):200-12. doi: 10.18553/jmcp.2011.17.3.200.
7
Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.使用质子泵抑制剂的老年患者发生社区获得性肺炎的风险。
Clin Infect Dis. 2012 Jan 1;54(1):33-42. doi: 10.1093/cid/cir767. Epub 2011 Nov 18.
8
Considerations for the use of proton-pump inhibitors in older adults.老年人使用质子泵抑制剂的注意事项。
Consult Pharm. 2012 Feb;27(2):114-20. doi: 10.4140/TCP.n.2012.114.
9
Deprescribing versus continuation of chronic proton pump inhibitor use in adults.成人慢性质子泵抑制剂的撤药与继续用药对比
Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD011969. doi: 10.1002/14651858.CD011969.pub2.
10
Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.艰难梭菌感染与质子泵抑制剂在成人和儿科患者中的关联程度和方向:系统评价和荟萃分析。
J Gastroenterol. 2018 Jan;53(1):84-94. doi: 10.1007/s00535-017-1369-3. Epub 2017 Jul 25.

引用本文的文献

1
Proton Pump Inhibitor Use Exceeding the U.S. Food and Drug Administration Approved Treatment Duration for Patients With Peptic Ulcer Disease: A Retrospective Cohort Study.质子泵抑制剂用于消化性溃疡疾病患者超过美国食品药品监督管理局批准的治疗时长:一项回顾性队列研究。
Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70152. doi: 10.1002/pds.70152.
2
Physicians' perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns.医生对质子泵抑制剂不良反应的认知与意识及其对处方模式的影响。
Front Pharmacol. 2024 Jun 26;15:1383698. doi: 10.3389/fphar.2024.1383698. eCollection 2024.
3
Evaluating physicians' awareness and prescribing trends regarding proton pump inhibitors: a cross-sectional study.评估医生对质子泵抑制剂的认知及处方趋势:一项横断面研究。
Front Pharmacol. 2023 Nov 9;14:1241766. doi: 10.3389/fphar.2023.1241766. eCollection 2023.
4
Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study.使用质子泵抑制剂的患者中炎症性肠病的患病率及相关危险因素:一项基于人群的研究。
Cureus. 2023 Jan 23;15(1):e34088. doi: 10.7759/cureus.34088. eCollection 2023 Jan.
5
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49-64 and 65-70 years old.美国 49-64 岁和 65-70 岁退伍军人中按多药疗法程度评估的潜在不适当药物使用。
Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1056-1074. doi: 10.1002/pds.5506. Epub 2022 Jul 15.
6
Use of Proton Pump Inhibitors With Dexamethasone in Patients With COVID-19 Pneumonia: Contributions to Long-Term Polypharmacy.在新冠肺炎患者中质子泵抑制剂与地塞米松联合使用:对长期多重用药的影响
Cureus. 2022 May 2;14(5):e24661. doi: 10.7759/cureus.24661. eCollection 2022 May.
7
Objective ambulatory pH monitoring and subjective symptom assessment of gastroesophageal reflux disease show type of carbohydrate and type of fat matter.胃食管反流病的客观动态pH监测和主观症状评估显示了碳水化合物类型和脂肪类型。
Therap Adv Gastroenterol. 2022 May 31;15:17562848221101289. doi: 10.1177/17562848221101289. eCollection 2022.
8
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.质子泵抑制剂使用者患 COVID-19 的风险增加。
Am J Gastroenterol. 2020 Oct;115(10):1707-1715. doi: 10.14309/ajg.0000000000000798.
9
Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.医生对质子泵抑制剂风险的认知及停药建议:一项全国性调查。
Am J Gastroenterol. 2020 May;115(5):689-696. doi: 10.14309/ajg.0000000000000558.
10
Internists' Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey.内科医生对质子泵抑制剂不良反应的认知及其对处方行为的影响:一项全国性调查结果
Gastroenterology Res. 2018 Feb;11(1):11-17. doi: 10.14740/gr944w. Epub 2018 Feb 23.

本文引用的文献

1
Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.质子泵抑制剂相关的不良风险:一项系统评价
Gastroenterol Hepatol (N Y). 2009 Oct;5(10):725-734.
2
An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.一种跨专业方法,用于减少成人内科和外科重症监护病房应激性溃疡预防措施的过度使用。
Ann Pharmacother. 2014 Apr;48(4):462-9. doi: 10.1177/1060028013517088. Epub 2014 Jan 28.
3
Evaluation of clinical pharmacy interventions in a Veterans Affairs medical center primary care clinic.评估退伍军人事务医疗中心初级保健诊所中的临床药学干预措施。
Am J Health Syst Pharm. 2013 Jul 1;70(13):1168-72. doi: 10.2146/ajhp120514.
4
Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.临床药师的建议对门诊医疗实践中质子泵抑制剂减量方案的影响。
J Manag Care Pharm. 2013 May;19(4):325-33. doi: 10.18553/jmcp.2013.19.4.325.
5
Guidelines for the diagnosis and management of gastroesophageal reflux disease.胃食管反流病诊断和管理指南
Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329. doi: 10.1038/ajg.2012.444. Epub 2013 Feb 19.
6
Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.临床药学服务对肾功能不全患者应激性溃疡预防用药及相关费用的影响。
Int J Pharm Pract. 2013 Aug;21(4):263-9. doi: 10.1111/ijpp.12005. Epub 2012 Nov 9.
7
Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease.质子泵抑制剂处方及其在美国被诊断为胃食管反流病的退伍军人中的后续使用。
J Gen Intern Med. 2013 Jul;28(7):930-7. doi: 10.1007/s11606-013-2345-0.
8
Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.质子泵抑制剂与失代偿性肝硬化退伍军人严重感染的发生率高有关。
Aliment Pharmacol Ther. 2012 Nov;36(9):866-74. doi: 10.1111/apt.12045.
9
Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?质子泵抑制剂:在临床实践中是否被过度使用,是否存在重大风险?
Int J Clin Pract. 2012 Jun;66(6):582-91. doi: 10.1111/j.1742-1241.2012.02921.x.
10
Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.使用质子泵抑制剂的老年患者发生社区获得性肺炎的风险。
Clin Infect Dis. 2012 Jan 1;54(1):33-42. doi: 10.1093/cid/cir767. Epub 2011 Nov 18.